Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL835238 | 0.88 | ABL1 (0.38) | ADORA2ASLC22A12PRMT5ADORA1 | |
| SCHEMBL834531 | 0.86 | SCN9A (0.39) | SCN9AADORA2AADORA2BSLC22A12ADORA1 | |
| SCHEMBL835228 | 0.83 | PDE4A (0.37) | PTGS2PTGS1ADORA2ASLC22A12ADORA1 | |
| SCHEMBL9172136 | 0.82 | CA1 (0.51) | CYP11B1CYP11B2CYP19A1CYP17A1CYP1A2 | |
| SCHEMBL834264 | 0.81 | PADI1 (0.43) | PTGS2PTGS1ADORA2AADORA2BADORA1 | |
| SCHEMBL7220134 | 0.80 | CYP19A1 (0.54) | ADORA2AADORA2BCYP11B1CYP19A1ADORA1 | |
| SCHEMBL835250 | 0.80 | ADORA2B (0.37) | SCN9AADORA2AADORA2BSLC22A12ADORA1 | |
| SCHEMBL830046 | 0.75 | CYP19A1 (0.54) | PTGS2ADORA2AADORA2BCYP11B1CYP11B2 | |
| SCHEMBL834263 | 0.75 | CYP19A1 (0.54) | PTGS2PTGS1ADORA2AADORA2BCYP19A1 | |
| SCHEMBL834528 | 0.75 | CYP2A6 (0.44) | PTGS2ADORA2AADORA2BCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | PTGS2 791/4885SCN9A 369/4885PTGS1 637/4885 |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | PTGS2 913/4885SCN9A 332/4885PTGS1 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.